Sheppard Pratt Health System

Unknown ownership

Research

The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.

Start Date: Mar 2021

Last Updated: Oct 2022

An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)

Start Date: Mar 2021

Last Updated: Dec 2021

The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation

Start Date: Mar 2022

Last Updated: Apr 2023

Douglas Pharmaceuticals Limited

EntheogeniX

Field Trip Health

Organic Flower

Otsuka

Toronto Center for Psychedelic Science